An innovative technology, ion robotic bronchoscopy, that can help interventional pulmonologists and thoracic surgeons diagnose lung cancer earlier is available at Robert Wood Johnson University Hospital together with Rutgers Cancer Institute in New Brunswick. The American Cancer Society says lung cancer is the leading cause of cancer death in the United States, accounting for about one in five of all cancer fatalities. The ACS estimates for lung cancer in the U.S. for 2025 are about 226,650 new cases of lung cancer (110,680 in men and 115,970 in women); about 124,730 deaths from lung cancer (64,190 in men and 60,540 in women).
Utilizing advanced technologies including AI, radiomics, and innovative technology (Ion robotic bronchoscopy), interventional pulmonologists and thoracic surgeons can diagnose lung cancer earlier. Using robotic-assisted bronchoscopy, doctors can now perform highly precise, minimally invasive biopsies on almost all nodules including the small, difficult-to-reach nodules in peripheral areas of the lungs where more than seven out of 10 of cancerous growths are located. To read the full story.